Double-blinded, Randomized, Active Control Comparative, Multicenter-designed, Phase III Clinical Trial to Evaluate the Safety and Efficacy for Improvement of Glabellar Lines of "Botulax" Compared to Botox Inj. in Patients With Moderate to Severe Glabellar Lines
Latest Information Update: 06 Jun 2015
Price :
$35 *
At a glance
- Drugs Letibotulinumtoxina (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
- Sponsors Hugel
- 06 Jun 2015 New trial record